Matches in SemOpenAlex for { <https://semopenalex.org/work/W4211246979> ?p ?o ?g. }
- W4211246979 endingPage "1186" @default.
- W4211246979 startingPage "1167" @default.
- W4211246979 abstract "Non-alcoholic steatohepatitis (NASH) has emerged as a major challenge for public health because of high global prevalence and lack of evidence-based therapies. Most animal models of NASH lack sufficient validation regarding disease progression and pharmacological treatment. The Gubra-Amylin NASH (GAN) diet-induced obese (DIO) mouse demonstrate clinical translatability with respect to disease etiology and hallmarks of NASH. This study aimed to evaluate disease progression and responsiveness to clinically effective interventions in GAN DIO-NASH mice. Disease phenotyping was performed in male C57BL/6J mice fed the GAN diet high in fat, fructose, and cholesterol for 28-88 weeks. GAN DIO-NASH mice with biopsy-confirmed NASH and fibrosis received low-caloric dietary intervention, semaglutide (30 nmol/kg/day, s.c.) or lanifibranor (30 mg/kg/day, p.o.) for 8 and 12 weeks, respectively. Within-subject change in nonalcoholic fatty liver disease (NAFLD) Activity Score (NAS) and fibrosis stage was evaluated using automated deep learning-based image analysis. GAN DIO-NASH mice showed clear and reproducible progression in NASH, fibrosis stage, and tumor burden with high incidence of hepatocellular carcinoma. Consistent with clinical trial outcomes, semaglutide and lanifibranor improved NAS, whereas only lanifibranor induced regression in the fibrosis stage. Dietary intervention also demonstrated substantial benefits on metabolic outcomes and liver histology. Differential therapeutic efficacy of semaglutide, lanifibranor, and dietary intervention was supported by quantitative histology, RNA sequencing, and blood/liver biochemistry. In conclusion, the GAN DIO-NASH mouse model recapitulates various histological stages of NASH and faithfully reproduces histological efficacy profiles of compounds in advanced clinical development for NASH. Collectively, these features highlight the utility of GAN DIO-NASH mice in preclinical drug development." @default.
- W4211246979 created "2022-02-13" @default.
- W4211246979 creator A5001683046 @default.
- W4211246979 creator A5004560260 @default.
- W4211246979 creator A5008386419 @default.
- W4211246979 creator A5031025187 @default.
- W4211246979 creator A5037471942 @default.
- W4211246979 creator A5047405265 @default.
- W4211246979 creator A5049482844 @default.
- W4211246979 creator A5052984593 @default.
- W4211246979 creator A5062070235 @default.
- W4211246979 creator A5067265775 @default.
- W4211246979 creator A5069251431 @default.
- W4211246979 creator A5075602116 @default.
- W4211246979 creator A5084253536 @default.
- W4211246979 creator A5088582143 @default.
- W4211246979 creator A5006733321 @default.
- W4211246979 date "2022-02-24" @default.
- W4211246979 modified "2023-10-01" @default.
- W4211246979 title "Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH" @default.
- W4211246979 cites W1970250630 @default.
- W4211246979 cites W1979288606 @default.
- W4211246979 cites W1990248309 @default.
- W4211246979 cites W1992116679 @default.
- W4211246979 cites W2017948134 @default.
- W4211246979 cites W2023461955 @default.
- W4211246979 cites W2033361774 @default.
- W4211246979 cites W2041447975 @default.
- W4211246979 cites W2065107673 @default.
- W4211246979 cites W2067740038 @default.
- W4211246979 cites W2113653640 @default.
- W4211246979 cites W2132715587 @default.
- W4211246979 cites W2139318977 @default.
- W4211246979 cites W2161872363 @default.
- W4211246979 cites W2161883681 @default.
- W4211246979 cites W2163484250 @default.
- W4211246979 cites W2182670456 @default.
- W4211246979 cites W2215535790 @default.
- W4211246979 cites W2469365710 @default.
- W4211246979 cites W2507524244 @default.
- W4211246979 cites W2519479884 @default.
- W4211246979 cites W2613180696 @default.
- W4211246979 cites W2730267177 @default.
- W4211246979 cites W2774655822 @default.
- W4211246979 cites W2783806692 @default.
- W4211246979 cites W2787846545 @default.
- W4211246979 cites W2789841804 @default.
- W4211246979 cites W2800258246 @default.
- W4211246979 cites W2810423511 @default.
- W4211246979 cites W2899389750 @default.
- W4211246979 cites W2899595328 @default.
- W4211246979 cites W2901814223 @default.
- W4211246979 cites W2901979245 @default.
- W4211246979 cites W2911080438 @default.
- W4211246979 cites W2924479779 @default.
- W4211246979 cites W2927712631 @default.
- W4211246979 cites W2929875152 @default.
- W4211246979 cites W2941033601 @default.
- W4211246979 cites W2953485865 @default.
- W4211246979 cites W2971782246 @default.
- W4211246979 cites W2984524859 @default.
- W4211246979 cites W2994912142 @default.
- W4211246979 cites W2997837979 @default.
- W4211246979 cites W3006306205 @default.
- W4211246979 cites W3013242926 @default.
- W4211246979 cites W3022387787 @default.
- W4211246979 cites W3022452643 @default.
- W4211246979 cites W3025611952 @default.
- W4211246979 cites W3034691659 @default.
- W4211246979 cites W3039496711 @default.
- W4211246979 cites W3084300541 @default.
- W4211246979 cites W3102426258 @default.
- W4211246979 cites W3109708108 @default.
- W4211246979 cites W3133746780 @default.
- W4211246979 cites W3138288621 @default.
- W4211246979 cites W3138431202 @default.
- W4211246979 cites W3160163020 @default.
- W4211246979 cites W3162136356 @default.
- W4211246979 cites W3163483026 @default.
- W4211246979 cites W3173984559 @default.
- W4211246979 cites W3193498370 @default.
- W4211246979 cites W3207086349 @default.
- W4211246979 cites W3208498374 @default.
- W4211246979 cites W4211246979 @default.
- W4211246979 doi "https://doi.org/10.1111/cts.13235" @default.
- W4211246979 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35143711" @default.
- W4211246979 hasPublicationYear "2022" @default.
- W4211246979 type Work @default.
- W4211246979 citedByCount "17" @default.
- W4211246979 countsByYear W42112469792022 @default.
- W4211246979 countsByYear W42112469792023 @default.
- W4211246979 crossrefType "journal-article" @default.
- W4211246979 hasAuthorship W4211246979A5001683046 @default.
- W4211246979 hasAuthorship W4211246979A5004560260 @default.
- W4211246979 hasAuthorship W4211246979A5006733321 @default.
- W4211246979 hasAuthorship W4211246979A5008386419 @default.
- W4211246979 hasAuthorship W4211246979A5031025187 @default.
- W4211246979 hasAuthorship W4211246979A5037471942 @default.